Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.
Taruna RajagopalArun SeshachalamArunachalam JothiKrishna Kumar RathnamSrikanth TalluriSivaramakrishnan VenkatabalasubranianNageswara Rao DunnaPublished in: Molecular biology reports (2022)
Our data advocates that South Indian women with higher grade TNBC tumors and without HBOC could be considered for BRCA mutation screening, thereby enabling enhanced decision-making and preventive therapy.